Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aratana Therapeutics Inc (NASDAQ:PETX)

7.74
Delayed Data
As of Jan 17
 -0.28 / -3.49%
Today’s Change
2.56
Today|||52-Week Range
10.73
+7.80%
Year-to-Date

Today’s Trading

Previous close8.02
Today’s open8.25
Day’s range7.73 - 8.30
Volume356,575
Average volume (3 months)540,441
Market cap$286.7M
Dividend yield--
Data as of 01/17/2017

Growth & Valuation

Earnings growth (last year)-88.46%
Earnings growth (this year)+70.68%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-11.60%
P/E ratioNM
Price/Sales282.75
Price/Book2.63

Competitors

 Today’s
change
Today’s
% change
ASMBAssembly Biosciences...+2.03+13.93%
OMEDOncoMed Pharmaceutic...-0.41-5.10%
CRVSCorvus Pharmaceutica...-0.06-0.42%
COCPCocrystal Pharma Inc-0.02-5.00%
Data as of 3:50pm ET, 01/17/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$678.0K
Annual profit (last year)-$84.1M
Net profit margin-12,397.35%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Steven St. Peter
Chief Operating Officer
Brent A. Standridge
Corporate headquarters
Leawood, Kansas

Forecasts


Search for Jobs